Lista de obras - Iñigo Landa - Dominio Público Uruguay

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

artículo científico publicado en 2010

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer

artículo científico publicado en 2015

An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.

artículo científico publicado en 2013

Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma

article

Association studies in thyroid cancer susceptibility: are we on the right track? ⬇️

artículo científico publicado el 3 de agosto de 2011

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

artículo científico publicado en 2019

Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer

artículo científico publicado en 2007

Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.

artículo científico publicado en 2011

Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis

artículo científico publicado en 2009

Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

artículo científico publicado en 2012

EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC

article

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

scientific article published on 07 February 2019

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

artículo científico publicado en 2011

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

scientific article published on 05 July 2013

Genetics of Human Thyroid Cancer Cell Lines-Response

scientific article published on 01 November 2019

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

artículo científico publicado en 2009

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

artículo científico publicado en 2016

Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

artículo científico publicado en 2012

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

artículo científico publicado en 2007

Mouse Models as a Tool for Understanding Progression in Braf-Driven Thyroid Cancers

artículo científico publicado en 2019

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

artículo científico publicado en 2015

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

artículo científico publicado en 2010

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

artículo científico publicado en 2010

Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.

artículo científico publicado en 2009

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

artículo científico publicado en 2010

SDHC mutation in an elderly patient without familial antecedents.

artículo científico publicado en 2008

Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake

scientific article published on 31 October 2019

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.

artículo científico publicado en 2013

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

artículo científico publicado en 2009

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

artículo científico publicado en 2015

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

artículo científico publicado en 2017

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes

artículo científico publicado en 2010

Lista de obras de Iñigo Landa

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer

An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.

Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma

Association studies in thyroid cancer susceptibility: are we on the right track? ⬇️

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer

Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.

Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis

Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

Genetics of Human Thyroid Cancer Cell Lines-Response

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

Mouse Models as a Tool for Understanding Progression in Braf-Driven Thyroid Cancers

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

SDHC mutation in an elderly patient without familial antecedents.

Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes